Failure of 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes

British Journal of Pharmacology

Volumn 127, Issue 3, 1999, Pages 693-700

  Wegener, Jörg W ^a   Closs, Ellen I ^a   Förstermann, Ulrich ^a   Nawrath, Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aortic smooth muscle; Cyclic GMP; Heart muscle; Myoglobin; ODQ

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CARBACHOL; CYCLIC GMP; ETHYLAMINE; GUANYLATE CYCLASE; MYOGLOBIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ENZYME INHIBITION; FEMALE; HEART MUSCLE CELL; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA, THORACIC; CARBACHOL; CELLS, CULTURED; CYCLIC GMP; ENZYME INHIBITORS; FEMALE; GUANYLATE CYCLASE; HEART VENTRICLES; MALE; MYOCARDIUM; NITRIC OXIDE DONORS; OXADIAZOLES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 0033037855     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702608     Document Type: Article

References (47)

1. + currents in frog cardiac myocytes. Br. J. Pharmacol., 121, 1369-1377.
2. Arnold, W.P., Mittal, C.K., Katsuki, S. & Murad, F. (1977). Nitric oxide activates guanylate cyclase and increases guanosine 3′: 5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U.S.A., 74, 3203-3207.
3. Balligand, J.L., Kelly, R.A., Marsden, P.A., Smith, T.W. & Michel, T. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U.S.A., 90, 347-351.
4. Balligand, J.L., Kobzik, L., Han, X., Kaye, D.M., Belhassen, L., O'Hara, D.S., Kelly, R.A., Smith, T.W. & Michel, T. (1995). Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem., 270, 14582-14586.
5. Baylor, S.M. & Pape, P.C. (1988). Measurement of myoglobin diffusivity in the myoplasm of frog skeletal muscle fibres. J. Physiol. (Lond.). 406, 247-275.
6. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. Brunner, F., Schmidt, K., Nielsen, E.B., & Mayer, B. (1996). Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther., 277, 48-53.
8. Cellek, S., Kasakov, L. & Moncada, S. (1996). Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br. J. Pharmacol., 118, 137-140.
9. Diamond, J., Teneick, R.E. & Trapani, A.J. (1977). Are increases in cyclic GMP levels responsible for the negative inotropic effects of acetylcholine in the heart? Biochem. Biophys. Res. Commun., 79, 912-918.
10. Doeller, J.F., & Wittenberg, B.A. (1991). Myoglobin function and energy metabolism of isolated cardiac myocytes: effect of sodium nitrite. Am. J. Physiol., 261, H53-H62.
11. Flesch, M., Kilter, H., Cremers, B., Lenz, O., Sudkamp, M., Kuhn-Regnier, F. & Bohm, M. (1997). Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J. Pharmacol. Exp. Ther., 281, 1340-1349.
12. Garthwaite, J. (1995). Neural nitric oxide signalling. Trends Neurosci., 18, 51-2.
13. Garthwaite, J., Southam, E., Boulton, C.L., Nielson, E.B., Schmidt, K. & Mayer, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184-188.
14. George, W.J., Busuttil, R.W., Paddock, R.J., White, L.A. & Ignarro, L.J. (1975). Opposing regulatory influences of cyclic guanosine monophosphate and cyclic adenosine monophosphate in the control of cardiac muscle contraction. Recent Adv. Stud. Cardiac Struct. Metab., 8, 243-250.
15. Gross, S.S. & Wolin, M.S. (1995). Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol., 57, 737-769.
16. Hare, J.M. & Colucci, W.S. (1995). Role of nitric oxide in the regulation of myocardial function. Prog. Cardiovasc. Dis., 38, 155-166.
17. Hebeiss, K. & Kilbinger, H. (1996). Differential effects of nitric oxide donors on basal and electrically evoked release of acetylcholine from guinea-pig myenteric neurones. Br. J. Pharmacol, 118, 2073-2078.
18. Ignarro, L.J. (1990). Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol., 30, 535-560.
19. Ishibashi, T., Hamaguchi, M., Kato, K., Kawada, T., Ohta, H., Sasage, H. & Imai, S. (1993). Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 553-561.
20. Jurgens, K.D., Peters, T. & Gros, G. (1994). Diffusivity of myoglobin in intact skeletal muscle cells. Proc. Natl. Acad. Sci. USA, 91, 3829-3833.
21. Kojda, G., Kottenberg, K., Nix, P., Schluter, K.D., Piper, H.M. & Noack, E. (1996). Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ. Res., 78, 91-101.
22. ca by carbachol and sodium nitroprusside. Pflügers Arch., 426, 419-426.
23. Lindemann, J.P. & Watanabe, A.M. (1988). Mechanism of adrenergic and cholinergic regulation of myocardial contractility. In: Physiology and Pathophysiology of the Heart, Second edition, ed. Sperelakis, N. pp 423-452. Boston: Kluwer Acad. Publishers.
24. Macdonell, K.L., Tibbits, G.F. & Diamond, J. (1995). cGMP elevation does not mediate muscarinic agonist-induced negative inotropy in rat ventricular cardiomyocytes. Am. J. Physiol., 269, H1905-H1912.
25. Martin, W., Villani, G.M., Jothianandan, D. & Furchgott, R.F. (1985). Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther., 232, 708-716.
26. Mayer, B., Brunner, F. & K. Schmidt, K. (1993). Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol., 45, 367-374.
27. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 268, 26286-26295.
28. Mittal, C.K., Arnold, W.P. & Murad, F. (1978). Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. J. Biol. Chem., 253, 1266-1271.
29. Moncada, S., Palmer, R.M.J. & Higgs, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
30. Moro, M.A., Russel, R.J., Cellek. S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W. & Moncada, S. (1996). Cyclic GMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
31. Murad, F. (1986). Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest., 78, 1-5.
32. Nawrath, H., Bäumner, D., Rupp, J. & Oelert, H. (1995). The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br. J. Pharmacol., 116, 3061-3067.
33. O'Brien, P.J., Shen, H., Mccutcheon, L.J., O'Grady, M., Byrne, P.J., Ferguson, H.W., Mirsalimi, M.S., Julian, R.J., Sargeant, J.M., Tremblay, R.R. & Blackwell, T.E. (1992). Rapid, simple and sensitive microassay for skeletal and cardiac muscle myoglobin and hemoglobin: use in various animals indicates functional role of myohemoproteins. Mol. Cell. Biochem., 112, 45-52.
34. Ohlstein, E.H., Wood, K.S. & Ignarro, L.J. (1982). Purification and properties of heme-deficient hepatic soluble guanylate cyclase: effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX. Arch. Biochem. Biophys., 218, 187-198.
35. Rand, M.J. & Li, C.G. (1995). Discrimination by the NO-trapping agent, carboxy-PTIO, between NO and the nitrergic transmitter but not between NO and EDRF. Br. J. Pharmacol., 116, 1906-1910.
36. Salas, E., Moro, M.A., Askew, S., Hodson, H.F., Butler, A.R., Radomski, M.W. & Moncada, S. (1994). Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br. J. Pharmacol., 112, 1071-1076.
37. Schrammel, A., Behrends, S., Schmidt, K., Koesling, D. & Mayer, B. (1996). Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol., 50, 1-5.
38. 2+-induced LDL oxidation by nitric oxide: a study using donors with different half-time of NO release. Biochem. Biophys. Res. Commun., 220, 306-309.
39. Smith, J.A., Shah, A.M. & Lewis, M.J. (1991). Factors released from endocardium of the ferret and pig modulate myocardial contraction. J. Physiol. (Lond.), 439, 1-14.
40. 2+-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-incrcasing effects of carbachol in ventricular cardiomyocytes. J. Pharmacol Exp. Ther., 266, 919-925.
41. Steiner, A.L., Parker, C.W. & Kipnis, D.M. (1972). Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem., 247, 1106-1113.
42. Strauer, B.E. (1973). Der Mechanismus der Nitroglyzerinwirkung vom Aspekt der Myokardkontraktilität Z. Kardiol., 62, 97-113.
43. Traylor, T.G. & Sharma, V.S. (1992), Why NO? Biochemistry, 31, 2847-2849.
44. Wegener, J.W., Closs, E.I., Förstermann, U. & Nawrath, H. (1998). Failure of ODQ to inhibit activation of soluble guanylyl cyclase in ventricular myocytes from rat hearts. Naunyn Schmiedeberg's Arch. Pharmacol., 357, R47.
45. Wegener, J.W. & Nawrath, H. (1995). Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes. Naunyn Schmiedeberg's Arch Pharmacol., 352, 322-330.
46. Weyrich, A.S., Ma, X.L., Buerke, M., Murohara, T., Armstead, V.E., Lefer, A.M., Nicolas, J.M., Thomas, A.P., Lefer, D.J. & Vinten-Johansen, J. (1994). Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ. Res., 75, 692-700.
47. Wyeth, R.P., Temma, K., Seifen, E. & Kennedy, R.H. (1996). Negative inotropic actions of nitric oxide require high doses in rat cardiac muscle. Pflügers Arch., 432, 678-684.